retatrutide news today october 2025 Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In Retatrutide, an experimental weight-loss drug,
Description
Numbness or weakness accompanies the sensitivity (possible nerve damage rather than sensitivity)
Nausea tends to be most pronounced in the days immediately following each weekly injection, then diminishes until the next dose
Thats commonly overlooked. Experts emphasize the importance of taking in enough protein every day, which is key to building muscle
Will my appetite return to normal if I stop
Because the weight loss process on GLP-1s is so fast, she said people need to be extra vigilant in their nutritional intake, specifically increasing their intake of protein, to avoid sarcopenic obesity
